A polymorphism in the 3′ untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: A nested case-control study

Breast Cancer Research

Volumn 9, Issue 1, 2007, Pages

  Cox, David G ^a,b   Buring, Julie ^b   Hankinson, Susan E ^a,b   Hunter, David J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HORMONE RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; SEX HORMONE; CYCLOOXYGENASE 2; MEMBRANE PROTEIN; PTGS2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; BREAST TUMOR; GENETICS; METABOLISM; RISK;

3' UNTRANSLATED REGIONS; ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; FEMALE; HUMANS; MEMBRANE PROTEINS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34248196674     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1635     Document Type: Article

References (21)

1. Hofseth LJ Ying L Identifying and defusing weapons of mass inflammation in carcinogenesis Biochim Biophys Acta 2006, 1765:74-84. 16169156
2. Backlund MG Mann JR Dubois RN Mechanisms for the prevention of gastrointestinal cancer: The role of prostaglandin E2 Oncology 2005, 69(Suppl 1):28-32.10.1159/000086629 16210874
3. Lee SH Williams MV Dubois RN Blair IA Cyclooxygenase-2-mediated DNA damage J Biol Chem 2005, 280:28337-28346. 10.1074/jbc.M504178200 15964853
4. Williams MV Lee SH Pollack M Blair IA Endogenous lipid hydroperoxide-mediated DNA-adduct formation in min mice J Biol Chem 2006, 281:10127-10133. 10.1074/jbc.M600178200 16449227
5. Blair IA Lipid hydroperoxide-mediated DNA damage Exp Gerontol 2001, 36:1473-1481. 10.1016/S0531-5565(01)00133-4 11525870
6. Walshe JM Swain SM Clinical aspects of inflammatory breast cancer Breast Dis 2005, 22:35-44. 16735785
7. Raju R Cruz-Correa M Chemoprevention of colorectal cancer Dis Colon Rectum 2006, 49:113-124. 10.1007/s10350-005-0170-1 16362805
8. Egan KM Stampfer MJ Giovannucci E Rosner BA Colditz GA Prospective study of regular aspirin use and the risk of breast cancer J Natl Cancer Inst 1996, 88:988-993. 10.1093/jnci/88.14.988 8667430
9. Harris RE Chlebowski RT Jackson RD Frid DJ Ascenseo JL Anderson G Loar A Rodabough RJ White E McTiernan A Breast cancer and nonsteroidal anti-inflammatory drugs: Prospective results from the Women's Health Initiative Cancer Res 2003, 63:6096-6101. 14522941
10. Sinicrope FA Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer Mol Carcinog 2006, 45:447-454. 10.1002/mc.20232 16688727
11. Martin Sanz P Hortelano S Bosca L Casado M Cyclooxygenase 2: understanding the pathophysiological role through genetically altered mouse models Front Biosci 2006, 11:2876-2888. 10.2741/2016 16720359
12. Lee HK Jeong S Beta-catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3'-UTR Nucleic Acids Res 2006, 34:5705-5714. 1636482 17040897 10.1093/nar/gkl698
13. Dixon DA Dysregulated post-transcriptional control of COX-2 gene expression in cancer Curr Pharm Des 2004, 10:635-646. 10.2174/ 1381612043453171 14965326
14. Rockhill B Willett WC Hunter DJ Manson JE Hankinson SE Spiegelman D Colditz GA Physical activity and breast cancer risk in a cohort of young women J Natl Cancer Inst 1998, 90:1155-1160. 10.1093/jnci/90.15.1155 9701365
15. Rexrode KM Lee IM Cook NR Hennekens CH Buring JE Baseline characteristics of participants in the Women's Health Study J Womens Health Gend Based Med 2000, 9:19-27. 10.1089/152460900318911 10718501
16. Hankinson SE Willett WC Manson JE Colditz GA Hunter DJ Spiegelman D Barbieri RL Speizer FE Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women J Natl Cancer Inst 1998, 90:1292-1299. 10.1093/jnci/90.17.1292 9731736
17. Halushka MK Fan JB Bentley K Hsie L Shen N Weder A Cooper R Lipshutz R Chakravarti A Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis Nat Genet 1999, 22:239-247. 10.1038/ 10297 10391210
18. Cox D Boillot C Canzian F Data mining: Efficiency of using sequence databases for polymorphism discovery Hum Mutat 2001, 17:141-150. 10.1002/ 1098-1004(200102)17:2<141::AID-HUMU6>3.0.CO;2-1 11180597
19. Brueggemeier RW Richards JA Petrel TA Aromatase and cyclooxygenases: enzymes in breast cancer J Steroid Biochem Mol Biol 2003, 86:501-507. 10.1016/S0960-0760(03)00380-7 14623550
20. Langsenlehner U Yazdani-Biuki B Eder T Renner W Wascher TC Paulweber B Weitzer W Samonigg H Krippl P The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk Clin Cancer Res 2006, 12:1392-1394. 10.1158/1078-0432.CCR-05-2055 16489098
21. Zhang Z Sheng H Shao J Beauchamp RD DuBois RN Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells Neoplasia 2000. 2:523-530. 1508084 11228545 10.1038/sj.neo.7900117